These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25160057)

  • 21. Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.
    McKenna SD; Feger G; Kelton C; Yang M; Ardissone V; Cirillo R; Vitte PA; Jiang X; Campbell RK
    J Pharmacol Exp Ther; 2007 Aug; 322(2):822-8. PubMed ID: 17495128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives.
    Khoshneviszadeh M; Ghahremani MH; Foroumadi A; Miri R; Firuzi O; Madadkar-Sobhani A; Edraki N; Parsa M; Shafiee A
    Bioorg Med Chem; 2013 Nov; 21(21):6708-17. PubMed ID: 23993677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and anti-inflammatory evaluation of PEGylated 4-methyl and 4,8-dimethylcoumarins.
    Pandey MK; Balwani S; Sharma PK; Parmar VS; Ghosh B; Watterson AC
    Eur J Pharm Sci; 2010 Jan; 39(1-3):134-40. PubMed ID: 19948217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new bergenin derivatives as potent inhibitors of inflammatory mediators NO and TNF-α.
    Shah MR; Arfan M; Amin H; Hussain Z; Qadir MI; Choudhary MI; VanDerveer D; Mesaik MA; Soomro S; Jabeen A; Khan IU
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2744-7. PubMed ID: 22437110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and anti-inflammatory activity of indole glucosinolates.
    Vo QV; Trenerry C; Rochfort S; Wadeson J; Leyton C; Hughes AB
    Bioorg Med Chem; 2014 Jan; 22(2):856-64. PubMed ID: 24360830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.
    Maitraie D; Hung CF; Tu HY; Liou YT; Wei BL; Yang SC; Wang JP; Lin CN
    Bioorg Med Chem; 2009 Apr; 17(7):2785-92. PubMed ID: 19278854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
    Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor necrosis factor-induced cell killing by tryptophan and indole.
    Yuhas Y; Holtmann H; Shemer-Avni Y; Sarov I; Wallach D
    Eur Cytokine Netw; 1990; 1(1):35-40. PubMed ID: 2102360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
    Hassan GS; Abou-Seri SM; Kamel G; Ali MM
    Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noble 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-isoindolinone derivatives. part I: synthesis and SAR studies for the inhibition of TNF-alpha production.
    Park JS; Baik KU; Cho JY; Yoo ES; Byun YS; Park MH
    Arch Pharm Res; 2001 Oct; 24(5):367-70. PubMed ID: 11693533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
    Xu Q; Huang L; Liu J; Ma L; Chen T; Chen J; Peng F; Cao D; Yang Z; Qiu N; Qiu J; Wang G; Liang X; Peng A; Xiang M; Wei Y; Chen L
    Eur J Med Chem; 2012 Jun; 52():70-81. PubMed ID: 22483089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo design TNF-alpha antagonistic peptide based on the complex structure of TNF-alpha with its neutralizing monoclonal antibody Z12.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    J Biotechnol; 2006 Aug; 125(1):57-63. PubMed ID: 16522339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties.
    Wrobleski ST; Chen P; Hynes J; Lin S; Norris DJ; Pandit CR; Spergel S; Wu H; Tokarski JS; Chen X; Gillooly KM; Kiener PA; McIntyre KW; Patil-Koota V; Shuster DJ; Turk LA; Yang G; Leftheris K
    J Med Chem; 2003 May; 46(11):2110-6. PubMed ID: 12747783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semi-synthetic analogs of pinitol as potential inhibitors of TNF-alpha cytokine expression in human neutrophils.
    Bhat KA; Shah BA; Gupta KK; Pandey A; Bani S; Taneja SC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1939-43. PubMed ID: 19268586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors.
    Bharate SB; Mahajan TR; Gole YR; Nambiar M; Matan TT; Kulkarni-Almeida A; Balachandran S; Junjappa H; Balakrishnan A; Vishwakarma RA
    Bioorg Med Chem; 2008 Aug; 16(15):7167-76. PubMed ID: 18625560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of indolyl-3-acetonitrile derivatives and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells.
    Kwon TH; Yoon IH; Shin JS; Lee YH; Kwon BJ; Lee KT; Lee YS
    Bioorg Med Chem Lett; 2013 May; 23(9):2571-4. PubMed ID: 23528295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.
    Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S
    Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.